Salbutamol benefits children with congenital myasthenic syndrome due to ALG2 mutation

Journal article

Open access

Peer reviewed

M. Salih, M.Z. Seidahmed, H.Y. El Khashab, D. Hicks, G.T. Farsani, S. Laval, J. Müller and H. Lochmüller

Journal of the neurological sciences, Vol.357, pp.e72-e72

15/10/2015

Files and links (1)

url

https://doi.org/10.1016/j.jns.2015.08.261View

Published (Version of record) Open

1 Record Views

Title: Salbutamol benefits children with congenital myasthenic syndrome due to ALG2 mutation
Creators - without role: M. Salih - King Saud University
M.Z. Seidahmed - Security Forces Hospital
H.Y. El Khashab - King Saud University
D. Hicks - Newcastle University
G.T. Farsani - Newcastle University
S. Laval - Newcastle University
J. Müller - Newcastle University
H. Lochmüller - Newcastle University
Publication Details: Journal of the neurological sciences, Vol.357, pp.e72-e72
Publisher: Elsevier B.V
Identifiers: 9946760308331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article